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In Brief
Fluoride toxicity mitigation systems are
widespread in nature. Nelson et al. have
developed a high-throughput small
molecule screen to identify compounds
that enhance the innate toxicity of fluoride
in bacteria. Compounds derived from the
initial hits exhibit improved function,
which suggests a route to creating novel
fluoride-mediated antibacterial agents.
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Fluoride is a ubiquitous anion that inhibits a wide
variety of metabolic processes. Here, we report the
identification of a series of compounds that enhance
fluoride toxicity in Escherichia coli and Strepto-
coccus mutans. These molecules were isolated by
using a high-throughput screen (HTS) for com-
pounds that increase intracellular fluoride levels as
determined via a fluoride riboswitch reporter fusion
construct. A series of derivatives were synthesized
to examine structure-activity relationships, leading
to the identification of compounds with improved ac-
tivity. Thus, we demonstrate that small molecule
fluoride toxicity agonists can be identified by HTS
from existing chemical libraries by exploiting a natu-
ral fluoride riboswitch. In addition, our findings sug-
gest that some molecules might be further optimized
to function as binary antibacterial agents when com-
bined with fluoride.
INTRODUCTION
Although fluoride is commonly added to oral hygiene products to
increase the strength of tooth enamel, it also has substantial anti-
bacterial effects (Barbier et al., 2010; Li, 2003). For example,
when in complex with a divalent metal ion and ADP, fluoride
forms a nonfunctional mimic of ATP that can inhibit enolase
(Curran et al., 1994; Qin et al., 2006), and similar complexes
can inhibit a large diversity of other metabolic enzymes including
phosphatases (Barbier et al., 2010; Nakai and Thomas, 1974).
Due to these general mechanisms for enzyme inhibition, fluoride
is toxic to organisms from all three domains of life.
Until recently, very little was known about how cells sense and
respond to fluoride toxicity. New insights into the genes and
mechanisms used by bacterial cells to overcome fluoride toxicity
were revealed by the discovery of fluoride-responsive ribo-
switches that control the expression of a number of genes
conferring resistance to fluoride (Baker et al., 2012). Ribo-
switches are structured RNAs that are typically found in the 50-
UTRs of bacterial mRNAs where they regulate the expression
of genes in response to binding a small molecule or ion (Breaker,
2011; Peselis and Serganov, 2014; Serganov and Nudler, 2013).
The most common gene associated with fluoride riboswitches,Chemistry & Biology 22,termed crcB (also called fex or fluc), codes for a fluoride-specific
channel protein (Baker et al., 2012; Li et al., 2013; Stockbridge
et al., 2013). Another commonly controlled gene, eriCF, encodes
a fluoride-selective antiporter (Baker et al., 2012; Stockbridge
et al., 2012). Numerous other genes presumably involved in miti-
gating fluoride toxicity are also associated with fluoride ribo-
switches (Baker et al., 2012).
An Escherichia coli strain in which the fluc gene was deleted
(Dfluc) is 200-fold more sensitive to fluoride (Baker et al.,
2012). Similarly, some eukaryotic species use homologous
channel proteins to improve resistance to fluoride toxicity (Li
et al., 2013), which underscores the importance of fluc to fluoride
detoxification. Moreover, the deleterious phenotype resulting
from fluc deletion in E. coli can be compensated by expressing
an eriCF gene derived from another bacterium (Baker et al.,
2012), indicating that the proteins expressed from eriCF appear
to be biologically equivalent to those encoded by fluc. These
findings demonstrate that a major strategy for overcoming
toxicity is for cells to eject fluoride into the environment.
We speculated that small molecules that specifically inhibit the
protein products Fluc or EriCF, increase the membrane perme-
ability of fluoride, or increase fluoride retention through some
other mechanism could enhance fluoride toxicity. If such mole-
cules could be found, then perhaps they could be optimized
and made to function as novel antibacterial chemotherapeutics,
particularly when used in combination with high fluoride concen-
trations. This speculation is supported by the fact that some pre-
viously characterized pore-forming antibacterial and antifungal
compounds have been demonstrated to enhance the cytotoxic
activity of fluoride (Li and Breaker, 2012; Nelson et al., 2014;
Zasloff and Steinberg, 1993). However, these existing molecules
only modestly increase fluoride toxicity, and no non-peptidic
molecules have been identified that increase fluoride toxicity
toward bacteria.
To identify novel fluoride toxicity agonists for bacteria, we
developed an HTS strategy based on an E. coli strain in which
a b-galactosidase reporter gene controlled by a fluoride ribo-
switch provides a readout of intracellular fluoride concentration
(Baker et al., 2012; Nelson et al., 2014). A number of studies
have been conducted to identify compounds that directly target
riboswitches and function as antibiotics (Blount and Breaker,
2006; Deigan and Ferre´-D’Amare´, 2011; Kim et al., 2009; Lee
et al., 2009; Lu¨nse et al., 2014a, 2014b; Mulhbacher et al.,
2010; Ster et al., 2013). By contrast, our study is designed to
exploit a riboswitch as a tool to identify compounds that target
other aspects of bacterial physiology. Hit compounds from the527–534, April 23, 2015 ª2015 Elsevier Ltd All rights reserved 527
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Figure 1. Structures of Hits from a High-Throughput Screen for
Compounds that Enhance Fluoride Uptake or RetentionHTS were validated via a variety of biochemical assays and were
shown to sensitize bacteria to fluoride. A brief survey of analogs
of the original hits identified more potent compounds with
enhanced fluoride sensitization activity. Overall, this study illus-
trates the potential for optimization of fluoride toxicity agonists
as antibacterial compounds.
RESULTS AND DISCUSSION
Design and Validation of a High-Throughput Screen for
Fluoride Toxicity Agonists
To efficiently screen large compound collections for molecules
that enhance fluoride uptake and/or retention, a method for the
rapid, facile, and inexpensive detection of intracellular fluoride
was needed. A number of methods exist for the detection of fluo-
ride, including small molecule sensors (Cametti and Rissanen,
2009, 2013), direct monitoring of 18F accumulation (Drescher
and Suttie, 1972; Li et al., 2013; Quissell and Suttie, 1972), and
YFP variants that fluoresce in the presence of fluoride (Jayara-
man et al., 2000). However, none of these methods are
sufficiently selective or sensitive to rapidly and easily detect
intracellular fluoride concentrations in bacteria. Therefore, we
designed a screen that utilized the most selective biosensor for
fluoride currently known: a recently discovered fluoride-sensing
riboswitch (Baker et al., 2012).
Specifically, we employed a previously described wild-type
(WT) E. coli strain in which a fluoride-sensing riboswitch from
Pseudomonas syringae controls the expression of a lacZ re-
porter gene in a fluoride concentration-dependent manner528 Chemistry & Biology 22, 527–534, April 23, 2015 ª2015 Elsevier(Baker et al., 2012; Nelson et al., 2014). Whereas most ribo-
switches control gene expression by regulating the formation
of an intrinsic transcription terminator stem or by regulating ac-
cess to the ribosome binding site of the mRNA, the precise
mechanism bywhich this specific riboswitch representative con-
trols gene expression has not been established. The relative
amount of fluoride present in cells can be established by quanti-
tatively measuring reporter gene expression. This is achieved by
the addition of 4-methyl-umbelliferyl-b-D-galactopyranoside
(4-MUG), which is a proto-fluorescent b-galactosidase sub-
strate. A Dfluc E. coli strain containing the riboswitch reporter
was utilized as a positive control for cells that uptake or retain
an unusually high amount of fluoride. Reporter gene expression
in theDfluc E. coli strain was 15- to 20-fold higher compared with
the WT strain.
HTS assays were performed using 1 mM fluoride, which is
considerably higher than the concentration of fluoride present
in most natural sources of water. However, this fluoride concen-
tration is far below that tolerated by WT E. coli cultures, which
can still grow at concentrations as high as 100 mM (Baker
et al., 2012). Although fluoride concentrations in the millimolar
range might seem high, amounts are known to vary widely in
the environment, and local concentrations will increase greatly
as relativelymodest amounts of fluoride are concentrated in soils
or surface water pools upon evaporation. Moreover, fluoride in
the form of HF will dominate under acidic conditions (HF pKa is
3.14), and this acidic form is far more bioavailable. Therefore,
bacteria that have genetic and biochemical responses to even
rare exposures to high fluoride concentrations or to low concen-
trations of fluoride under slightly acidic conditions have a large
selective advantage. Our chemical screening approach is target-
ing this considerable capacity of bacteria to overcome the toxic
effects of high concentrations of fluoride.
After optimizing screening conditions, approximately 75,000
compounds from Chembridge, Maybridge, ChemDiv, and pro-
prietary Yale small molecule libraries were tested. In all cases,
Z0 values (Zhang et al., 1999) did not vary beyond 0.5 and 1,
and typically ranged between 0.6 and 0.8. The ratio of the fluo-
rescence signal of the positive control well (fluoride-treatedDfluc
cells) to background (average fluorescence of all wells on a plate)
was higher than 15:1. The action of each compound, when
added to WT cells with fluoride, was established by determining
a score between 1 and 100, where 1 represents fluorescence of
WT cells treated with fluoride alone and 100 represents fluores-
cence of fluoride-treated Dfluc cells. Hit compounds that yielded
a signal greater than 3-fold above background (scores typically
above 4) were chosen for further analysis. Hit compounds that
are inherently fluorescent were discarded, after which the hit
rate was approximately 1%.
Hit validation consisted of repeating the screening assay and
confirming that the signal increase was only observed in the
presence of both cells and fluoride, resulting in five molecules
that were chosen for future analysis (Figure 1 and Table S1). Of
these five hits, compound 1 was the most active, yielding an
approximately 8-fold increase in reporter signal at 32 mM when
10 mM sodium fluoride was present relative to the addition of
fluoride alone (Figure 2A). These compounds do not increase
the activity of the b-galactosidase enzyme in vitro, and there
was no increase in fluorescence upon treatment of cellsLtd All rights reserved
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Figure 2. Small Molecules Enhance Fluo-
ride Uptake and Toxicity in E. coli
(A) Reporter activity in E. coli treated with 1 and
NaF. Data points are the average of three repli-
cates and error bars represent SDs. Decreases in
reporter expression at high sodium fluoride and 1
are due to cell growth inhibition. See Figure S1 for
additional control experiments.
(B) Growth of bacteria cultured in the absence or
presence of 1 and increasing concentrations of
sodium fluoride following 16 hr of incubation at
37C. DMSO (1% [v/v] in the growth medium)
was used to solubilize and deliver test com-
pounds. Data points are the average of three
replicates and error bars represent SDs.containing a reporter construct carrying a fluoride riboswitch
with a disruptive mutation (Figure S1). These results are consis-
tent with our hypothesis that 1 increases intracellular fluoride
concentrations.
We next assessed whether 1 enhances the antibacterial activ-
ity of fluoride. Although 1 did not significantly change theminimal
inhibitory concentration (MIC) of fluoride toward E. coli, it did
reproducibly enhance the ability of 1 to slow E. coli growth (Fig-
ure 2B). Addition of 1 alone at 3.2 mM causes no decrease in the
viability of E. coli but enhances the natural toxicity of fluoride.
These results demonstrate that high-throughput screening of a
small molecule library with cells carrying a fluoride-dependent
reporter gene can reveal compounds that exhibit antibacterial
activity in the presence of fluoride. However, given the modest
enhancement in fluoride toxicity generated by 1, we sought to
identify analogs with improved activity.
Structure-Activity Relationships
All five selected hits isolated from the HTS contained an elec-
tron-deficient aryl group linked by either an amide or urea to
another ring system. To better understand the possible shared
pharmacophore and to identify more potent fluoride toxicity
agonists, a small library of related compounds was synthesized
with high yield and purity. This was achieved via one-step
coupling of acyl chlorides, isocyanates, or isothiocyanates to a
variety of commercially available aniline derivatives (Figure 3).
The fluoride-sensing riboswitch reporter strain was again used
to assess the extent to which each compound increased intra-
cellular fluoride concentration.
The relative activities of various analogs (Figure 4 and Table
S2) confirmed that an electron-deficient aromatic ring, such as
those in compounds 6 and 7 (Figures 4B and 4C), were indeed
necessary for enhancing intracellular fluoride concentrations.
The locations and identities of the electron-withdrawing groups,
however, do not appear to be of critical importance (e.g., see 6,
8, and 9). Notably, carboxamide-linked compounds were gener-
ally less active than the corresponding urea- or thiourea-linked
compounds (e.g., see 9–11). The most potent compounds (14–
17) all include a trifluoro-substituted aryl ring, suggesting that
this moiety is particularly beneficial for activity. A graphical sum-
mary of the structure-activity relationships (SAR) (Figure 5) de-
notes the importance of these electron-withdrawing moieties,Chemistry & Biology 22,and the presence of hydrogen-bond donor groups in the urea
or thiourea linker.
Interestingly, the SAR data derived from substitutions within
the urea-linked series was not the same as with thiourea-linked
(e.g., see 12 and 13). This suggests that the determinants of ac-
tivity for these two series might be different. It is possible that the
compounds from the two series might enhance fluoride toxicity
via different mechanisms. Alternatively, the preferred conforma-
tions of the urea-linked molecules may be distinct from the thio-
urea-linked examples (Lepore et al., 1973; Brooks et al., 2006;
Bryantsev and Hay, 2006), which could potentially generate the
differences in the activities we observe.
Hit Derivatives with Enhanced Fluoride-Dependent
Toxicity
We expected that compounds with improved activity in the fluo-
ride riboswitch reporter assay might also enhance the antibacte-
rial activity of fluoride. Specifically, we sought to identify analogs
that stop bacterial growth rather than simply slow replication as
is observed for compound 1, our most active initial hit (Figure 2).
Accordingly, we chose to examine the ability of our best urea- or
thiourea-linked compounds (based on the fluorescence assay)
to enhance the toxicity of fluoride to certain bacteria. Treatment
with a subinhibitory concentration (0.53MIC) of 14 resulted in a
greater than 8-fold improvement in the MIC of fluoride against
E. coli and a 2-fold improvement against Streptococcus mu-
tans, a causative agent of gingivitis (Figure 6). A subinhibitory
concentration of 17 was less effective at increasing fluoride
toxicity compared with 14. However, 17 achieves its more
modest effects at a lower concentration. In addition, we
observed significant bacterial toxicity for certain compounds in
the absence of any added fluoride (Figures 4 and 6). No
enhancement of fluoride toxicity was observed upon treatment
with ciprofloxacin (Figure S2).
Our findings are consistent with the hypothesis that thesemol-
ecules might enhance fluoride toxicity by targeting a cellular pro-
cess that is critical for cell growth even in the absence of fluoride.
However, their antibacterial effects are enhanced by the pres-
ence of fluoride. Importantly, the concentrations of fluoride
used in our study are substantially higher than bacteria typically
experience in a natural environment, except for those exposed to
fluoride-containing oral hygiene products. Thus, any use of such527–534, April 23, 2015 ª2015 Elsevier Ltd All rights reserved 529
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Figure 3. Synthesis of Analogs for Struc-
ture-Activity Relationship Analysescompounds as potential antibacterial agents would likely require
the concomitant application of additional fluoride.
There are several possible mechanisms by which these mole-
cules may be acting. The simplest might be that the compounds
disrupt bacterial membranes in a manner that allows fluoride to
more rapidly enter cells. There is precedence for compounds
that disrupt membrane integrity to enhance fluoride toxicity (Li
and Breaker, 2012; Nelson et al., 2014; Zasloff and Steinberg,
1993). Compounds that create nonspecific ion pores in cell
membranes should permit the rapid equilibrium between fluoride
outside and inside cells.
Curiously, evidence presented to date convincingly demon-
strates that Fluc-type ion channels permit the selective and pas-
sive diffusion of fluoride through membranes (Stockbridge et al.,
2013; Ji et al., 2014), and so members of this protein class theo-
retically allow fluoride transport both into and out of cells. How-
ever, the large negative membrane potential of bacterial cells
should greatly favor fluoride efflux through the channel (Stock-
bridge et al., 2013). Also, under slightly acidic conditions, fluoride
is expected to accumulate in cells relative to the environment
(Stockbridge et al., 2013; Li et al., 2013), and therefore fluoride
outflow should again be favored.
By contrast, amphotericin B increases fluoride toxicity to
fungal cells presumably by allowing fluoride to pass either way
across cell membranes, resulting in enhanced fluoride toxicity
(Zasloff and Steinberg, 1993; Li and Breaker, 2012). One key dif-
ference between Fluc proteins and compounds such as ampho-
tericin B is that the protein channel is highly specific for fluoride.
Formation of nonselective ion pores or general membrane
disruption will also disrupt the membrane potential of the cell,
which is critical for the productive use of Fluc channel proteins
to expel fluoride from inside the cell. In this regard, it is interesting
to note that various sodium-proton antiporters are believed to
be controlled by fluoride riboswitches, and this might be critical
for maintaining a negative membrane potential to facilitate fluo-
ride movement out of cells. The disruption of membranes in a
nonspecific fashion via various externally added compounds
will also disrupt membrane potential. Thus, these compounds
might either directly facilitate the transport of fluoride into cells
or, by disrupting membrane potential, inhibit its transport out
(Nelson et al., 2014).
Some similarities exist between our molecules and known in-
hibitors of bacterial cell wall biosynthesis (Li et al., 2003; Fran-
cisco et al., 2004) and lipid biosynthesis (Russell, 2004). It is
possible that the disruption of these processes could potentially
enhance fluoride transport into cells. Furthermore, the specific
nature of the hits obtained via our HTS would suggest these
compounds might function by interacting with a specific target
rather than by nonspecifically disrupting membranes. General
membrane disruptors should be far more tolerant of changes
to chemical substructures than our SAR data indicate.
Alternatively, the compounds could inhibit Fluc or some other
transporter that is necessary to eject fluoride as it slowly enters530 Chemistry & Biology 22, 527–534, April 23, 2015 ª2015 Elseviercells, resulting in an increase in fluoride retention. However,
given that so little is known about fluoride toxicity mitigation
mechanisms in bacteria, it is not yet possible to rule out a mech-
anism involving the inhibition of some other process that is crit-
ical for fluoride exclusion or expulsion from cells.
Intriguingly, some of our hits are also structurally similar
to known small molecule fluoride receptors (Boiocchi et al.,
2004). Receptors for fluoride and other anions often utilize diaryl
ureas or thioureas as hydrogen-bond donors to bind anions
(Davis et al., 2010), and the removal of one such potential
hydrogen-bond donor results in a dramatic decrease in com-
pound activity (Figure 4, 18). Furthermore, incorporation of fluo-
rine and trifluoromethyl substituents onto aryl rings of small
molecule chloride binders is known to improve their ability to
transport chloride across phospholipid membranes (Busschaert
et al., 2011, 2012).
Since we observe that the incorporation of similar substituents
onto the aryl rings of our molecules enhances fluoride uptake
and/or retention of E. coli (Figure 4 and Table S2), it is tempting
to speculate that the compounds identified in the current study
function as membrane-permeant fluoride binders that directly
facilitate the transport of fluoride into bacteria. To evaluate this
hypothesis, we examined 19 (Figure 4), which is a compound
known to promote the transport of chloride out of lipid vesicles
(Busschaert et al., 2012). This compound exhibits the greatest
ability to increase fluoride toxicity when tested with Strepto-
coccus mutans (Figure 6). This finding suggests that the com-
pound series identified in our HTS might indeed function by
directly facilitating the transport of fluoride into bacteria. How-
ever, additional studies are needed to convincingly establish
the true mechanism of action.
Concluding Remarks
Our findings indicate that small nonpeptidic molecules can be
used to increase fluoride toxicity against bacteria and that
such molecules might be frequently identified as hit compounds
via high-throughput screening. Compounds that could find utility
as fluoride toxicity agonists should have a number of character-
istics. First, for the development of broad-spectrum agents, a
good hit compound should have a provable mechanism that dis-
rupts a key component of the fluoride defense system used by
many bacteria or fungi. Second, a hit compound should be a
member of a molecular series that has the potential to be
improved through the synthesis and testing of analogs. Third,
the optimized agent to be used in a useful formulation should
induce strong fluoride toxicity against the pathogen but remain
nontoxic to the host when used alone or in combination with
fluoride.
The fluoride riboswitch reporter system used in this study is
sufficiently robust that it can be used to reveal hit compounds
by HTS that only weakly increase the intracellular concentration
of fluoride in bacteria. Our chemical library was modest in com-
pound number and diversity, and therefore it is not surprisingLtd All rights reserved
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Figure 4. Increase in Reporter Expression for Selected Hit Analogs
(A) Structures of selected compounds synthesized or purchased for determi-
nation of SAR. Analytical data are presented in the Supplemental Information.
(B) Reporter gene expression in E. coli treated with 6 and various concentra-
tions of fluoride. When 6 was tested at or above 10 mM, bacterial growth was
inhibited in 100 mM fluoride. Data points are the average of three replicates.
Error bars are the SD of the measurement.
(C) Reporter gene expression in E. coli treated with 7 and various concentra-
tions of fluoride. Details are as described for (B).
(D) Fold increase in reporter gene expression in E. coli treated with compound
and 10mMNaF. Values are normalized to thatmeasuredwith cells treatedwith
fluoride in the absence of any compound (value set to 1, dashed line). White
bars indicate the addition of 10 mM compound, while black bars indicate the
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Figure 5. Summary of Structure-Activity Relationships
Incorporation of electron-withdrawing groups (EWG) at the meta or para po-
sition of either aryl ring results in enhanced activity. Utilization of a thiourea
typically has little effect on activity compared with a urea, and likewise the
asymmetric incorporation of an additional ring system has little effect. Both
amide protons are necessary for activity and might be important for hydrogen
bonding (dashed lines).
Chemistry & Biology 22,that nearly all identified hits were based on the same chemical
scaffold. Although this collection of hits likely operate by a similar
mechanism, it is likely that many other compounds that increase
fluoride toxicity by different mechanisms could be identified by
our HTS process. Although additional chemically distinct mole-
cules were rarely observed to increase fluoride reporter expres-
sion, fluoride toxicity agonists with different chemical scaffolds
and mechanisms likely remain to be discovered. Novel com-
pounds with diversemechanismsmight bemore easily identified
in larger and more diverse libraries.
Regardless, we have succeeded in identifying novel small
molecules able to render bothGram-positive andGram-negative
bacteria susceptible to fluoride. Optimization of the ability of
these molecules to enhance fluoride toxicity via additional
rounds of SAR studies could yield antimicrobial agents that
when combined with fluoride offer a novel mechanism of action.
The fluoride riboswitch reporter system described in this study
could be used throughout this optimization process to determine
whether new compounds in the lead series can increase fluoride
concentration in cells. There are numerous challenges ahead for
those who seek to create compounds that could conceivably be
used in topical formulations in conjunction with fluoride in a novel
antibacterial approach, but, given the spread of antibiotic-resis-
tant bacteria, such novel approaches are needed.
SIGNIFICANCE
Herein we describe a high-throughput screen that exploits a
fluoride-sensing riboswitch to regulate reporter gene
expression in E. coli. This screen was successfully used
to isolate compounds that increase intracellular fluoride
concentrations. Hit compounds identified with this screen
reproducibly increase reporter gene expression and
enhance the ability of fluoride to slow bacterial growth.
Based on SAR data, additional and more potent analogs
were identified by the synthesis of analogs. The most
potent derivatives substantially increase the antibacterial
potency of fluoride toward representative Gram-negativeaddition of 100 mMcompound, with the exceptions of 1, 14, and 15 (32 mM) and
16 and 17 (3.2 mM). The absence of a bar indicates no substantial bacterial
growth was observed for that condition. See Table S2 for data on additional
compounds tested.
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A B C Figure 6. Structural Derivatives of Hit Com-
pounds Enhance Fluoride Toxicity
(A) MIC of hit compounds for E. coli and S. mutans
in the absence of fluoride. Arrows indicate that the
values for the analyses denoted by the symbols
were notmeasurable at the highest concentrations
tested.
(B) Decrease in the MIC of sodium or potassium
fluoride for E. coli in the presence of varying con-
centrations of hit compounds. For compounds
with a MIC in the absence of fluoride higher than
32 mg ml1, half and quarter MIC values were
calculated as if the MIC were 64 mg ml1. Values
are the average of three replicates.
(C) Decrease in the MIC of sodium or potassium
fluoride for S. mutans in the presence of varying
concentrations of hit compounds. Values are the
average of three replicates.and Gram-positive bacteria. There are numerous potential
mechanisms of action for these compounds and for other
such agents that might be identified in the future, including
the disruption of cell barriers or the direct transport of fluo-
ride across bacterial membranes. Additional molecules that
enhance fluoride toxicity could conceivably be optimized for
use as antibacterial or antifungal agents when used in
conjunction with this anion.
EXPERIMENTAL PROCEDURES
Riboswitch Reporter Expression Analyses
Reporter gene expression analyses were performed as described previously
with some modifications (Nelson et al., 2014). E. coli transformed with fluoride
reporter constructs in pRS414 (Baker et al., 2012) were grown with aeration
overnight in lysogeny broth (LB) supplemented with 75 mg ml1 carbenicillin
at 37C. 8 ml of either the overnight culture or the culture diluted 1:10 with
fresh LB were then added to 96-well plates containing 36 ml of 23 modified
LB (20 g l1 tryptone and 10 g l1 yeast extract) and 36 ml of various concen-
trations of aqueous NaF. Cultures not supplemented with NaF were instead
supplemented with 1 mM NaCl (final concentration). 0.8 ml of compound dis-
solved in DMSO was added and the plates were sealed with parafilm and
grown, with shaking, at 37C for either 4 hr (1:10 diluted; data presented in
Tables S1 and S2) or overnight (1:100; all other data). Cultures grown without
compound contained 0.8 ml of DMSO alone.
Following incubation, bacterial growth was determined by measuring the
optical density at 600 nm. Reporter gene expression was established by first
adding 80 ml of modified Z buffer (60 mM Na2HPO4, 40 mM NaH2PO4,
10 mM KCl, 1 mM MgSO4 [pH 7.0] at 25
C), followed by 40 ml of 4-methylum-
belliferyl-b-D-galactopyranoside (1 mg ml1 in 50:50 v/v deionized H2O/
DMSO). Samples were mildly agitated and allowed to stand at room temper-
ature for 15 min. The reaction was halted by the addition of Na2CO3 and
gene expression was measured via fluorescence (excitation 360 nm, emission
460 nm).
High-throughput screening was performed largely as described above, with
some modifications. LB supplemented with 1 mM sodium fluoride was added
in 10 ml volumes to each well of 384-well plates. 20 nl of a 10 mM solution of
each compound to be tested was added via pronging, followed by the addition
of 10 ml of an overnight culture of E. coli containing the fluoride reporter. WT
and Dfluc E. coli cells, as well as media alone, were included on each plate
as controls. Bacteria were grown by shaking in a humidified incubator at
37C for 24 hr, at which time reporter gene expression was assayed as
described above.
Chemical Synthesis
Diaryl ureas were synthesized by the one-step coupling of various anilines with
various isocyanates in preweighed 1-dram (3.7-ml) vials. Each aniline532 Chemistry & Biology 22, 527–534, April 23, 2015 ª2015 Elsevier(0.05 mmol) was placed in the vial and dissolved in dichloromethane
(1.5 ml), to which the isocyanate (0.05mmol) was added. The vials were sealed
and stirred overnight at room temperature. In most cases, the product urea
precipitated or crystalized from the reaction. The solid was isolated from the
reaction by drawing the solution away from the solid with a fine tipped glass
pipette. The solid was washed with dichloromethane and the liquid was again
withdrawn. In the few cases where solid did not precipitate from the reaction,
the reaction was evaporated under a stream of nitrogen and the resulting solid
was washed with 1:1 ether/hexanes to yield the purified product. Solids were
air dried in the vial and then placed under high vacuum. Proton and fluorine nu-
clear magnetic resonance (NMR) and liquid chromatography-mass spectrom-
etry (LC-MS) were obtained for each compound to verify identity and purity,
which was greater than 90% for all compounds tested. Isolated yields were
60%–90%.
Diarylthioureas were synthesized exactly as described above using isothio-
cyanates in place of isocyanates, except reactions were stirred for 3 days to
ensure completion. Many of the thiourea products were soluble in dichlorome-
thane necessitating the above-described evaporation and trituration proce-
dure. Solids were air dried in the vial and then placed under high vacuum.
Proton and fluorine NMR and LC-MS were obtained on each compound to
verify identity and purity, which was greater than 90% for all compounds
tested. Isolated yields were 50%–90%.
Arylbenzamides were synthesized by adding the aniline (0.29 mmol) to
1-dram vials. Silicycle morpholine resin (1.3 mmol) was added followed by
the addition of dry tetrahydrofuran (1.5 ml) and, subsequently, 4-trifluoro-
methyl benzoyl chloride (49 ml, 0.29 mmol) was added. The reaction was
stirred overnight before Silicycle amine resin (0.30 mmol) was added to
quench any excess acyl chloride. Additional dry tetrahydrofuran was
added as needed to aid stirring. After 24 hr, the reactions were filtered
through a pipette with a cotton plug with the aid of tetrahydrofuran
and the filtrates were further filtered using a syringe and a 0.45-mm
polytetrafluoroethylene syringe tip filter. The solutions were evaporated
under a stream of nitrogen and dried under high vacuum. Proton and
fluorine NMR and LC-MS were obtained for each compound to verify
identity and purity, which was greater than 90% for all compounds
tested. Isolated yields were 60%–90%. Compounds that were not synthe-
sized were purchased from Chembridge, Maybridge, or Sigma-Aldrich
(compound 19).
The solubility of selected compounds in LB and 0.1 M Tris (pH 7.0 at 25C)
was determined via nephelometry. NMR spectroscopy data for key com-
pounds (those in Figure 4, with the exception of 19, which was purchased
from Sigma-Aldrich) were obtained using an Agilent 400 mHz spectrometer
equipped with an auto tunable probe. LC-MS spectra were obtained using
an Agilent 1260 infinity liquid chromatograph attached to an Agilent 6120
quadrupole mass spectrometer. The compounds were eluted using an
increasing gradient of acetonitrile (0.1% formic acid) and water. The gradient
varied from 10% acetonitrile to 100% acetonitrile over 2 min with a total run
time of 5 min. Compounds were separated using an Agilent Eclipse plus
C18 5.1 3 50 mm column and monitored at 254 nm.Ltd All rights reserved
Bacterial Growth Curves and MIC Determinations
Bacteria were grown as described above, overnight, and diluted 1:10 in 23 LB.
8 ml of the resulting solution was then added to 42 ml of 23 modified LB and
42 ml of aqueous NaF, to which 0.8 ml of either DMSO or 1 dissolved in
DMSO was added. Cultures were then incubated in a 100-well Honeycomb
plate at 37C in a Bioscreen C system (Growth Curves USA) as described pre-
viously (Nelson et al., 2014).
MIC assays were conducted in a final volume of 100 ml according to
methods established by the Clinical Laboratory Standards Institute (CLSI,
2012). Briefly, test or control compound dissolved in DMSO or water as
appropriate was serially diluted (1:2) into successive tubes of the same sol-
vent. A 5-ml aliquot of each dilution was transferred to the appropriate wells
of 96-well clear round-bottom plates. To each dilution series, 95 ml of a
freshly prepared bacterial suspension was added with mixing to provide a
final bacterial inoculum of approximately 105–106 colony-forming units per
well and a final DMSO concentration of 5%. DMSO was added regardless
of whether the compound was dissolved in water or DMSO. Cation-adjusted
Mueller-Hinton broth (Fluka) was used for all MIC assays, and lysed horse
blood (Cleveland Scientific) was included at a final concentration of 5% for
assays with S. mutans. Assay cultures were incubated for 18–24 hr at
37C and in an atmosphere enriched to 5% CO2 for S. mutans. The MIC is
defined as the lowest concentration of antimicrobial agent that completely in-
hibits the growth of the organism as detected by the unaided eye. Ciproflox-
acin was used for comparison with a known antibiotic and as a benchmark
for each screening assay.
SUPPLEMENTAL INFORMATION
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